Episodios

  • Episode 603: Topical minoxidil for androgenetic alopecia: When blood pressure agents make you hairy
    Jun 10 2025
    In episode 603, James and Mike K invite Jennifer Young back to the podcast to talk about the best available evidence for topical minoxidil and hair growth. We discuss outcomes such as the numbers of hairs per squared centimeter – the main outcome reported – but when available, we also other report on other outcomes […]
    Más Menos
    27 m
  • Episode 602: Side effects of long-term PPI use: Leaving a bad taste in your mouth?
    Jun 6 2025
    In episode 602, James and Mike Kolber go over the best available evidence for the benefits and the harms for one of the most commonly used classes of medications – proton pump inhibitors. We find out the benefit numbers are much larger than the harm numbers. Check out the podcast to get all the numbers […]
    Más Menos
    30 m
  • Episode 6: Presenting balanced information about benefits and harms to patients makes you more contented
    May 27 2025
    THE CASE Dr Ashville is training to be a family physician and gets a phone call from a disgruntled patient called Jane Brown. She got a message saying “As your Cardiovascular risk is now 10% it is recommended you take a statin medication”. She is a bit cross she didn’t get a proper conversation about […]
    Más Menos
    1 h y 9 m
  • Episode 5: Does spending the right amount of time on lifestyle advice make clinicians more contented?
    Apr 30 2025
    THE CASE Nurse J and advanced nurse practitioner and Dr A are taking a short coffee break and discussing the management of lifestyle issues in their mixed practice. Many of their patients are living in poverty, with a lot of patients having Long Term Conditions. They feel under pressure from health service management to push […]
    Más Menos
    1 h y 16 m
  • Episode 601: Gabapentinoids for fibromyalgia – do they ease the pain?
    Apr 18 2025
    In episode 601, James and Mike invite Jennifer Young back to the podcast to go over all the evidence we have for pregabalin and gabapentin in patients with fibromyalgia. During the discussion we find out how many people actually get a ≥30% reduction in pain compared to placebo. We even look at some information about […]
    Más Menos
    37 m
adbl_web_global_use_to_activate_webcro805_stickypopup